Literature DB >> 7731141

Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy.

M Akmal1, R R Barndt, A N Ansari, J G Mohler, S G Massry.   

Abstract

Calcification of the lungs occurs in chronic renal failure (CRF) and may adversely affect both pulmonary and right ventricular function. The present study examined the role of excess parathyroid hormone (PTH) in the genesis of pulmonary calcifications in dogs with experimental CRF and evaluated calcium content of lungs, diffusing lung capacity (DCO), mean pulmonary artery pressure (MPAP), right ventricular pressure (RVP), and right ventricular hypertrophy (RVH) in six normal, six with CRF, and six thyroparathyroidectomized (CRF-PTX) dogs. CRF-PTX animals were maintained normocalcemic and euthyroid. The degree and duration of CRF were not different between the two groups with CRF. The mean value of the serum PTH in CRF dogs was 166 +/- 42 microliters Eq/ml, but was undetectable in CRF-PTX animals. Thallium scan provided evidence consistent with RVH in CRF dogs but not in CRF-PTX animals. Calcium content of lungs was markedly elevated in CRF dogs (7656 +/- 1657 mg/kg dry wt) but modestly increased in CRF-PTX (1057 +/- 117 mg/kg dry wt) as compared to normal (673 +/- 34 mg/kg dry wt). RVP and MPAP were significantly (P < 0.01) higher and DCO significantly lower in CRF dogs than in normal or CRF-PTX animals. These parameters were not different in the latter two group of dogs. In three additional dogs with CRF of one year duration which were followed for an additional year after parathyroidectomy, these abnormalities were corrected.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731141     DOI: 10.1038/ki.1995.18

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients.

Authors:  Zhilian Li; Shuangxin Liu; Xinling Liang; Wenjian Wang; Hongwen Fei; Penghua Hu; Yuanhan Chen; Lixia Xu; Ruizhao Li; Wei Shi
Journal:  Int Urol Nephrol       Date:  2013-06-21       Impact factor: 2.370

Review 2.  Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.

Authors:  Sanjiv J Shah
Journal:  J Cardiovasc Transl Res       Date:  2017-06-05       Impact factor: 4.132

3.  Pulmonary hypertension in end-stage renal disease and post renal transplantation patients.

Authors:  Esam H Alhamad; Mohammed Al-Ghonaim; Hussam F Alfaleh; Joseph P Cal; Nazmi Said
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

4.  Risk factors for pulmonary hypertension in maintenance hemodialysis patients: a cross-sectional study.

Authors:  Yanjun He; Yuling Wang; Xingying Luo; Jianting Ke; Yi Du; Mi Li
Journal:  Int Urol Nephrol       Date:  2015-11       Impact factor: 2.370

5.  Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease.

Authors:  Lei Zhang; Shaoyan Yang; Jianling Chen; Jinling Ma; Yueqin Ren
Journal:  Int Urol Nephrol       Date:  2017-02-27       Impact factor: 2.370

6.  The case for routine parathyroid hormone monitoring.

Authors:  Stuart M Sprague; Sharon M Moe
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-04       Impact factor: 8.237

7.  Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.

Authors:  Sankar D Navaneethan; Jason Roy; Kelvin Tao; Carolyn S Brecklin; Jing Chen; Rajat Deo; John M Flack; Akinlolu O Ojo; Theodore J Plappert; Dominic S Raj; Ghulam Saydain; James H Sondheimer; Ruchi Sood; Susan P Steigerwalt; Raymond R Townsend; Raed A Dweik; Mahboob Rahman
Journal:  J Am Soc Nephrol       Date:  2015-09-18       Impact factor: 10.121

Review 8.  Calcium as a cardiovascular toxin in CKD-MBD.

Authors:  Sharon M Moe
Journal:  Bone       Date:  2016-08-27       Impact factor: 4.398

9.  The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients.

Authors:  Gursel Acarturk; Ramazan Albayrak; Mehmet Melek; Seref Yuksel; Ihsan Uslan; Huseyin Atli; Mehmet Colbay; Mehmet Unlu; Fatma Fidan; Zerrin Asci; Soner Cander; Ozcan Karaman; Murat Acar
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

10.  Pulmonary hypertension in dialysis patients: a cross-sectional italian study.

Authors:  Fabio Fabbian; Stefano Cantelli; Christian Molino; Marco Pala; Carlo Longhini; Francesco Portaluppi
Journal:  Int J Nephrol       Date:  2010-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.